CORREGENE Trademark

Trademark Overview


On Tuesday, November 9, 2021, a trademark application was filed for CORREGENE with the United States Patent and Trademark Office. The USPTO has given the CORREGENE trademark a serial number of 97115917. The federal status of this trademark filing is REGISTERED as of Tuesday, February 14, 2023. This trademark is owned by Corregene Biotechnology Co., Ltd.. The CORREGENE trademark is filed in the Pharmaceutical Products category with the following description:

Cultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological tissue cultures for veterinary purposes; stem cells for veterinary purpose...
corregene

General Information


Serial Number97115917
Word MarkCORREGENE
Filing DateTuesday, November 9, 2021
Status700 - REGISTERED
Status DateTuesday, February 14, 2023
Registration Number6977479
Registration DateTuesday, February 14, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 29, 2022

Trademark Statements


Goods and ServicesCultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; enzyme preparations for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; biological tissue cultures for veterinary purposes; stem cells for veterinary purposes
Pseudo MarkCORRE GENE; CORE GENE
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 26, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorregene Biotechnology Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChangping, Beijing 102200
CN

Party NameCorregene Biotechnology Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChangping, Beijing 102200
CN

Party NameCorregene Biotechnology Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChangping, Beijing 102200
CN

Trademark Events


Event DateEvent Description
Tuesday, February 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 14, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 24, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 24, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, August 26, 2022NON-FINAL ACTION E-MAILED
Friday, August 26, 2022NON-FINAL ACTION WRITTEN
Friday, August 19, 2022ASSIGNED TO EXAMINER
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 12, 2021NEW APPLICATION ENTERED